RenovoRx Raises FY2026 Sales Guidance
RenovoRx raises FY2026 sales outlook to $3.750M-$4.250M
RenovoRx (NASDAQ: RNXT ) raises FY2026 sales outlook from $3.000 million-$4.000 million to $3.750 million-$4.250 million vs $3.203 million estimate.
RenovoRx raises FY2026 sales outlook to $3.750M-$4.250M
RenovoRx (NASDAQ: RNXT ) raises FY2026 sales outlook from $3.000 million-$4.000 million to $3.750 million-$4.250 million vs $3.203 million estimate.